The Pain, Opioid and Ultra Low Dose Naltrexone LDN Documentary

The LDN Research Trust released a documentary earlier this month that provides education for patients that are suffering from chronic pain and are dependent on opioid prescription medication.

At the Medicine Center Pharmacy we strive to help educate patients and the medical profession to use an alternative, inexpensive, effective treatment. Watch Pain Specialists talk about using Ultra and Low Dose Naltrexone to treat their patients with Chronic Pain. Our thanks to the speakers in alphabetical order: Asher Goldstein MD, John Kim MD, Neel Mehta MD, Norman Marcus MD, Pradeep Chopra MD, Samyadev Datta MD. This program is not sponsored by any pharmaceutical manufacturer, it is funded by donations to the LDN Research Trust which has been a driving force in providing LDN education and research around the world.

This documentary was produced to potentially help millions of people worldwide who are suffering from chronic pain and have become addicted to prescription medications through no fault of their own and still, they suffer from Chronic pain. We aim to help educate the medical profession and governments to use an alternative, inexpensive, effective treatment.

You can learn more about low dose naltrexone at one of our monthly patient education seminars or by contacting the pharmacy. You can register here for the next seminar: Register Here

Featured
Low Dose Naltrexone: The Most Underutilized Therapy In Medicine
Low Dose Naltrexone: The Most Underutilized Therapy In Medicine

Do you suffer from fibromyalgia, chronic fatigue, autoimmune disease, inflammation, or chronic pain?

Low Dose Naltrexone (LDN) is gaining attention as a potential therapy that may help regulate the immune system and reduce inflammation—yet most patients and providers have never heard of it.

Join this free webinar to learn how LDN works, who may benefit, and how personalized compounding makes it possible.

How LDN supports autoimmune conditions & chronic inflammation - Brad White, R.Ph., Featured on the “Made to Be Whole” Podcast
How LDN supports autoimmune conditions & chronic inflammation - Brad White, R.Ph., Featured on the “Made to Be Whole” Podcast

Compounding pharmacist Brad White was recently featured on the Made to Be Whole podcast, diving deep into the power of Low Dose Naltrexone (LDN) and the essential role of compounding pharmacies in personalized healthcare.

Low Dose Naltrexone (LDN) in Autoimmune Diseases: Recent Research Findings
Low Dose Naltrexone (LDN) in Autoimmune Diseases: Recent Research Findings

Autoimmune diseases are a complex group of conditions in which the immune system mistakenly attacks healthy cells and tissues. While treatment options exist to manage symptoms, there is no known cure for autoimmune diseases. However, recent research has shed light on the potential benefits of Low Dose Naltrexone (LDN) in managing these conditions. In this blog post, we'll explore some of the latest research findings on the use of LDN in autoimmune diseases.

516px-Naltrexone_skeletal.svg.png
Low Dose Naltrexone applications in Crohn’s Disease
LDN and Mood Disorders
LDN and Mood Disorders

Low Dose Naltrexone (LDN) is increasingly used by clinicians for management of challenging medical conditions such as chronic pain or autoimmune disorders.

Low Dose Naltrexone for Epilepsy
Low Dose Naltrexone for Epilepsy

Epilepsy is a broad term used to describe people who suffer multiple seizures in their life time. Seizures are defined as sudden, uncontrolled electrical brain activity. Depending on how the brain looks at these electrical currents a person may change behavior, display abnormal movement or even lose consciousness. Low Dose Naltrexone has shown promise as an alternative treatment option for seizure disorders.

Low-Dose Naltrexone (LDN) Use in Cancer Patients
Low-Dose Naltrexone (LDN) Use in Cancer Patients

Naltrexone is classified as an opioid antagonist. Naltrexone blocks opiate drugs from binding to the opioid receptors, which can result in increased endorphin and enkephalin release. This causes a biological response that results in reduced signaling and release of inflammatory substances, nerve cell inflammation and autoimmune mediators. LDN has been studied across a wide variety of autoimmune conditions and cancer diagnosis.

Low Dose Naltrexone and the Theorized Treatment of the Novel Coronavirus
Low Dose Naltrexone and the Theorized Treatment of the Novel Coronavirus

COVID-19 sparks an inflammatory immune response that is essential to control and eliminate the infection, however, certain immune responses can cause a decrease of gas exchange in the lungs.

The Pain, Opioid and Ultra Low Dose Naltrexone LDN Documentary
The Pain, Opioid and Ultra Low Dose Naltrexone LDN Documentary

The LDN Research Trust released a documentary earlier this month that provides education for patients that are suffering from chronic pain and are dependent on opioid prescription medication.

Could Targeting Brain Inflammation Be The Answer To Alzheimer's Disease?
Could Targeting Brain Inflammation Be The Answer To Alzheimer's Disease?

Autoimmune conditions like Alzheimer’s Disease may be linked to chronic inflammation of nervous system. Does the future of new treatments focus on controlling inflammation and how can low dose naltrexone play a role?

LDN (Low-Dose Naltrexone)Medicine Centerldn, ldnresearchtrustComment